Journal article icon

Journal article

Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.

Abstract:

The management of Crohn's disease is rapidly changing. The advent of potent immunomodulatory and biologic therapies has led to more demanding endpoints for clinical trials than only clinical response and remission. Complete withdrawal of corticosteroids, healing of endoscopically visible lesions, and prevention of structural damage are only a few new endpoints that are finding their way into the clinical trials of today and those that are being developed for the future. Given the importance o...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1002/ibd.21034

Authors


Journal:
Inflammatory bowel diseases More from this journal
Volume:
15
Issue:
10
Pages:
1599-1604
Publication date:
2009-10-01
DOI:
EISSN:
1536-4844
ISSN:
1078-0998
Language:
English
Keywords:
Pubs id:
pubs:112081
UUID:
uuid:aa8e722d-dba0-4338-b121-e2c1b7c86cce
Local pid:
pubs:112081
Source identifiers:
112081
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP